HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasma Cell Leukemia

A rare, aggressive variant of MULTIPLE MYELOMA characterized by the circulation of excessive PLASMA CELLS in the peripheral blood. It can be a primary manifestation of multiple myeloma or develop as a terminal complication during the disease.
Also Known As:
Leukemia, Plasma Cell; Leukemias, Plasma Cell; Leukemias, Plasmacytic; Plasma Cell Leukemias; Plasmacytic Leukemias; Leukemia, Plasmacytic; Plasmacytic Leukemia
Networked: 383 relevant articles (33 outcomes, 27 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Multiple Myeloma
2. Plasmacytoma
3. Residual Neoplasm
4. Amyloidosis
5. Smoldering Multiple Myeloma

Experts

1. Neri, Antonino: 10 articles (09/2021 - 02/2005)
2. Musto, Pellegrino: 7 articles (09/2021 - 06/2007)
3. Todoerti, Katia: 7 articles (09/2021 - 06/2013)
4. Bashir, Qaiser: 6 articles (07/2022 - 01/2019)
5. Nishihori, Taiga: 6 articles (07/2022 - 12/2011)
6. Ronchetti, Domenica: 6 articles (09/2021 - 02/2005)
7. Efebera, Yvonne: 5 articles (07/2022 - 12/2015)
8. Hari, Parameswaran: 5 articles (07/2022 - 12/2020)
9. Shah, Nina: 5 articles (01/2022 - 01/2019)
10. Kharfan-Dabaja, Mohamed A: 5 articles (07/2021 - 12/2011)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Plasma Cell Leukemia:
1. Bortezomib (Velcade)FDA Link
2. Dexamethasone (Maxidex)FDA LinkGeneric
3. Melphalan (Alkeran)FDA LinkGeneric
4. daratumumabIBA
5. Lenalidomide (CC 5013)FDA Link
6. Thalidomide (Thalomid)FDA Link
7. Cyclophosphamide (Cytoxan)FDA LinkGeneric
8. bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
9. venetoclaxIBA
10. Doxorubicin (Adriamycin)FDA LinkGeneric

Therapies and Procedures

1. Therapeutics
2. Stem Cell Transplantation
3. Combination Drug Therapy (Combination Chemotherapy)
4. Drug Therapy (Chemotherapy)
5. Aftercare (After-Treatment)